Synonyms:
Status: Phase 1
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: 5F1CN52GFM

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Receptor tyrosine-protein kinase erbB-3 inhibitor PubMed PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Carcinoma, Squamous Cell 1 D002294 ClinicalTrials
Esophageal Neoplasms 1 D004938 ClinicalTrials
Breast Neoplasms 1 D001943 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4298013
FDA SRS 5F1CN52GFM